yanqi ye
University of North Carolina at Chapel Hill
Chapel Hill, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of North Carolina at Chapel Hill
Chapel Hill, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Lewis Katz School of Medicine, Temple University
Philadelphia, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Nanyang Technological University
Singapore, Singapore
Review Editor
Cancer Molecular Targets and Therapeutics
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Cancer Molecular Targets and Therapeutics
City of Hope National Medical Center
Duarte, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Campus Bio-Medico University
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National Institute of Health (ISS)
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Shandong University
Jinan, China
Review Editor
Cancer Molecular Targets and Therapeutics
Stanford University
Stanford, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Guangzhou Medical University
Guangzhou, China
Review Editor
Cancer Molecular Targets and Therapeutics
Mayo Clinic
Rochester, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Virginia Tech
Blacksburg, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Albert Einstein College of Medicine
New York City, United States
Review Editor
Cancer Molecular Targets and Therapeutics